ERBB2 and breast carcinoma: These tumors are being increasingly recognized as a distinct group of breast cancers: “Triple Positive Breast Cancer” (TPBC) (68, 86, 87), whose unique biology is shaped by a complex interplay of HER2 and ER signaling (88–91).